January 9, 2017 | FDA Office of Minority Health
FDA OMH DRAFT GUIDANCE WEBINAR
Join us on Tuesday, January 24, 2017 from 12:00 pm – 1:00 pm EST to learn about our recently released guidance document Collection of Race and Ethnicity Data in Clinical Trials-Guidance for Industry and FDA Staff. Speakers will include FDA Assistant Commissioner for Minority Health Dr. Jonca Bull and OMH's Dr. Martin Mendoza.
Last Fall, the FDA Office of Minority Health (OMH) issued a draft guidance document to outline FDA's expectations for and recommendations on use of a standardized approach for collecting and reporting race and ethnicity data in submissions for clinical trials for FDA regulated medical products conducted in the United States and abroad. The webinar will highlight the importance of the inclusion of appropriate populations in trials by sponsors, as well as the use of standard terminology for age, sex, gender, race, and ethnicity with the goal of ensuring that subpopulation data is collected consistently.
You can register and find more information about the webinar on the Eventbrite page. If you have any questions, please feel free to emails us at firstname.lastname@example.org.
FDA Office of Minority Health
Let's create a world where health equity is a reality for all.